Barkley PMHNP CHaPter Quiz 3
VersioN 2.0 a well detailed oNe
writteN aNd graded
a+ uPgraded
Title: AdvancedPsychiatric-Mental Health Nurse Practitioner
Certification Examination: Comprehensive Assessment of
Psychopharmacology, Neurobiology, Clinical Diagnostics, and
Evidence-Based Psychotherapeutic Interventions for Complex
Psychiatric Populations
Difficulty Level: Advanced / Hard
Target Audience: PMHNP candidates preparing for board certification (ANCC or AANP),
advanced practice nursing students, and psychiatric-mental health professionals seeking
rigorous exam preparation
Instructions
Select the single best answer for each question. Questions are designed to test clinical
reasoning, application of DSM-5-TR criteria, psychopharmacological principles, neurobiological
concepts, and evidence-based psychiatric care. Each question has one correct answer and four
distractors.
Section 1: Neurobiology and Pathophysiology (Questions 1-25)
,1. A 32-year-old patient with treatment-resistant depression is being evaluated for
esketamine nasal spray therapy. Which neurobiological mechanism is primarily responsible
for esketamine's rapid antidepressant effects?
A. Inhibition of monoamine oxidase with subsequent dopamine elevation
B. Non-competitive NMDA receptor antagonism with downstream AMPA receptor activation
C. Selective serotonin reuptake inhibition with 5-HT1A agonism
D. Dopamine D2 receptor partial agonism with 5-HT2A antagonism
Correct Answer: B
Rationale: Esketamine, the S-enantiomer of ketamine, exerts its rapid antidepressant effects
primarily through non-competitive antagonism of NMDA receptors, leading to increased
glutamate transmission and AMPA receptor stimulation. This triggers a cascade of intracellular
signaling pathways, including mTOR activation and increased BDNF synthesis, resulting in rapid
synaptogenesis. Option A describes MAOIs, C describes SSRIs with 5-HT1A activity, and D
describes atypical antipsychotic mechanisms.
2. A 28-year-old patient presents with auditory hallucinations, delusions, and disorganized
speech. Neuroimaging reveals decreased frontal lobe activity and increased striatal
dopamine. Which neurotransmitter system is most directly implicated in this presentation?
A. Serotonin dysfunction in the raphe nuclei
B. Dopamine dysregulation in the mesolimbic and mesocortical pathways
C. Norepinephrine overactivity in the locus coeruleus
D. Acetylcholine deficiency in the basal forebrain
Correct Answer: B
Rationale: The dopamine hypothesis of schizophrenia posits that positive symptoms
(hallucinations, delusions) are related to mesolimbic dopamine hyperactivity, while negative and
cognitive symptoms are related to mesocortical dopamine hypoactivity. Serotonin,
norepinephrine, and acetylcholine play roles but are not the primary systems implicated in this
classic presentation.
3. A 65-year-old patient presents with progressive memory loss, visuospatial deficits, and
difficulty with executive function. Neuroimaging reveals bilateral hippocampal atrophy and
amyloid deposition on PET scan. Which neurobiological finding is most characteristic of this
presentation?
,A. Tau protein aggregation in the substantia nigra
B. Amyloid-beta plaques and neurofibrillary tangles
C. Lewy body deposition in the brainstem
D. TDP-43 inclusions in the frontal and temporal lobes
Correct Answer: B
Rationale: This presentation is classic for Alzheimer's disease, characterized by amyloid-beta
plaques (extracellular) and neurofibrillary tangles (intracellular hyperphosphorylated tau).
Hippocampal atrophy is a hallmark finding. Tau aggregation in the substantia nigra is seen in
progressive supranuclear palsy, Lewy bodies in dementia with Lewy bodies, and TDP-43 in
frontotemporal dementia.
4. A patient with major depressive disorder has failed multiple antidepressant trials. The
PMHNP considers the role of inflammation in depression. Which inflammatory marker is most
consistently elevated in treatment-resistant depression?
A. Erythrocyte sedimentation rate (ESR)
B. C-reactive protein (CRP)
C. Interleukin-6 (IL-6)
D. Tumor necrosis factor-alpha (TNF-α)
Correct Answer: C
Rationale: IL-6 is one of the most consistently elevated inflammatory cytokines in treatment-
resistant depression. It is associated with sickness behavior, HPA axis dysregulation, and reduced
neuroplasticity. CRP and TNF-α are also elevated but with less consistency. ESR is a non-specific
marker of inflammation and not specifically associated with TRD.
5. A 45-year-old patient with schizophrenia shows poor response to multiple antipsychotics.
Genetic testing reveals a CYP2D6 poor metabolizer phenotype. This enzyme is primarily
responsible for metabolizing which of the following antipsychotics?
A. Clozapine
B. Quetiapine
C. Haloperidol
D. Olanzapine
Correct Answer: C
Rationale: CYP2D6 is a major enzyme involved in the metabolism of haloperidol, as well as
other typical antipsychotics like fluphenazine and perphenazine. Clozapine is primarily
, metabolized by CYP1A2 and CYP3A4. Quetiapine is metabolized by CYP3A4. Olanzapine is
primarily metabolized by CYP1A2 and UGT enzymes. Poor metabolizer status for CYP2D6 can
lead to increased haloperidol levels and side effects.
6. A patient with generalized anxiety disorder is started on a serotonin-norepinephrine
reuptake inhibitor (SNRI). The therapeutic effect is most likely related to which
neurobiological change?
A. Immediate increase in synaptic serotonin and norepinephrine
B. Downregulation of presynaptic 5-HT1A autoreceptors and alpha-2 adrenergic receptors
C. Upregulation of GABA-A receptors in the amygdala
D. Increased dopamine release in the prefrontal cortex
Correct Answer: B
Rationale: SNRIs increase synaptic serotonin and norepinephrine immediately, but therapeutic
effects in anxiety disorders typically take 2-6 weeks. This delay is attributed to downstream
adaptive changes, including desensitization and downregulation of somatodendritic 5-HT1A
autoreceptors and presynaptic alpha-2 adrenergic autoreceptors, which enhance
neurotransmission in projection areas. This is consistent with the neurobiological model of
anxiety.
7. Which neuroanatomical structure is most critically involved in fear acquisition and is a key
target for exposure-based therapies in anxiety disorders?
A. Hippocampus
B. Amygdala
C. Prefrontal cortex (ventromedial)
D. Periaqueductal gray
Correct Answer: B
Rationale: The amygdala is central to fear acquisition and the formation of fear memories.
Successful exposure therapy is associated with decreased amygdala activation and increased
prefrontal cortex (vmPFC) inhibition of the amygdala. The hippocampus is involved in contextual
learning, the vmPFC in fear extinction, and the periaqueductal gray in fear responses, but the
amygdala is central to fear acquisition.
VersioN 2.0 a well detailed oNe
writteN aNd graded
a+ uPgraded
Title: AdvancedPsychiatric-Mental Health Nurse Practitioner
Certification Examination: Comprehensive Assessment of
Psychopharmacology, Neurobiology, Clinical Diagnostics, and
Evidence-Based Psychotherapeutic Interventions for Complex
Psychiatric Populations
Difficulty Level: Advanced / Hard
Target Audience: PMHNP candidates preparing for board certification (ANCC or AANP),
advanced practice nursing students, and psychiatric-mental health professionals seeking
rigorous exam preparation
Instructions
Select the single best answer for each question. Questions are designed to test clinical
reasoning, application of DSM-5-TR criteria, psychopharmacological principles, neurobiological
concepts, and evidence-based psychiatric care. Each question has one correct answer and four
distractors.
Section 1: Neurobiology and Pathophysiology (Questions 1-25)
,1. A 32-year-old patient with treatment-resistant depression is being evaluated for
esketamine nasal spray therapy. Which neurobiological mechanism is primarily responsible
for esketamine's rapid antidepressant effects?
A. Inhibition of monoamine oxidase with subsequent dopamine elevation
B. Non-competitive NMDA receptor antagonism with downstream AMPA receptor activation
C. Selective serotonin reuptake inhibition with 5-HT1A agonism
D. Dopamine D2 receptor partial agonism with 5-HT2A antagonism
Correct Answer: B
Rationale: Esketamine, the S-enantiomer of ketamine, exerts its rapid antidepressant effects
primarily through non-competitive antagonism of NMDA receptors, leading to increased
glutamate transmission and AMPA receptor stimulation. This triggers a cascade of intracellular
signaling pathways, including mTOR activation and increased BDNF synthesis, resulting in rapid
synaptogenesis. Option A describes MAOIs, C describes SSRIs with 5-HT1A activity, and D
describes atypical antipsychotic mechanisms.
2. A 28-year-old patient presents with auditory hallucinations, delusions, and disorganized
speech. Neuroimaging reveals decreased frontal lobe activity and increased striatal
dopamine. Which neurotransmitter system is most directly implicated in this presentation?
A. Serotonin dysfunction in the raphe nuclei
B. Dopamine dysregulation in the mesolimbic and mesocortical pathways
C. Norepinephrine overactivity in the locus coeruleus
D. Acetylcholine deficiency in the basal forebrain
Correct Answer: B
Rationale: The dopamine hypothesis of schizophrenia posits that positive symptoms
(hallucinations, delusions) are related to mesolimbic dopamine hyperactivity, while negative and
cognitive symptoms are related to mesocortical dopamine hypoactivity. Serotonin,
norepinephrine, and acetylcholine play roles but are not the primary systems implicated in this
classic presentation.
3. A 65-year-old patient presents with progressive memory loss, visuospatial deficits, and
difficulty with executive function. Neuroimaging reveals bilateral hippocampal atrophy and
amyloid deposition on PET scan. Which neurobiological finding is most characteristic of this
presentation?
,A. Tau protein aggregation in the substantia nigra
B. Amyloid-beta plaques and neurofibrillary tangles
C. Lewy body deposition in the brainstem
D. TDP-43 inclusions in the frontal and temporal lobes
Correct Answer: B
Rationale: This presentation is classic for Alzheimer's disease, characterized by amyloid-beta
plaques (extracellular) and neurofibrillary tangles (intracellular hyperphosphorylated tau).
Hippocampal atrophy is a hallmark finding. Tau aggregation in the substantia nigra is seen in
progressive supranuclear palsy, Lewy bodies in dementia with Lewy bodies, and TDP-43 in
frontotemporal dementia.
4. A patient with major depressive disorder has failed multiple antidepressant trials. The
PMHNP considers the role of inflammation in depression. Which inflammatory marker is most
consistently elevated in treatment-resistant depression?
A. Erythrocyte sedimentation rate (ESR)
B. C-reactive protein (CRP)
C. Interleukin-6 (IL-6)
D. Tumor necrosis factor-alpha (TNF-α)
Correct Answer: C
Rationale: IL-6 is one of the most consistently elevated inflammatory cytokines in treatment-
resistant depression. It is associated with sickness behavior, HPA axis dysregulation, and reduced
neuroplasticity. CRP and TNF-α are also elevated but with less consistency. ESR is a non-specific
marker of inflammation and not specifically associated with TRD.
5. A 45-year-old patient with schizophrenia shows poor response to multiple antipsychotics.
Genetic testing reveals a CYP2D6 poor metabolizer phenotype. This enzyme is primarily
responsible for metabolizing which of the following antipsychotics?
A. Clozapine
B. Quetiapine
C. Haloperidol
D. Olanzapine
Correct Answer: C
Rationale: CYP2D6 is a major enzyme involved in the metabolism of haloperidol, as well as
other typical antipsychotics like fluphenazine and perphenazine. Clozapine is primarily
, metabolized by CYP1A2 and CYP3A4. Quetiapine is metabolized by CYP3A4. Olanzapine is
primarily metabolized by CYP1A2 and UGT enzymes. Poor metabolizer status for CYP2D6 can
lead to increased haloperidol levels and side effects.
6. A patient with generalized anxiety disorder is started on a serotonin-norepinephrine
reuptake inhibitor (SNRI). The therapeutic effect is most likely related to which
neurobiological change?
A. Immediate increase in synaptic serotonin and norepinephrine
B. Downregulation of presynaptic 5-HT1A autoreceptors and alpha-2 adrenergic receptors
C. Upregulation of GABA-A receptors in the amygdala
D. Increased dopamine release in the prefrontal cortex
Correct Answer: B
Rationale: SNRIs increase synaptic serotonin and norepinephrine immediately, but therapeutic
effects in anxiety disorders typically take 2-6 weeks. This delay is attributed to downstream
adaptive changes, including desensitization and downregulation of somatodendritic 5-HT1A
autoreceptors and presynaptic alpha-2 adrenergic autoreceptors, which enhance
neurotransmission in projection areas. This is consistent with the neurobiological model of
anxiety.
7. Which neuroanatomical structure is most critically involved in fear acquisition and is a key
target for exposure-based therapies in anxiety disorders?
A. Hippocampus
B. Amygdala
C. Prefrontal cortex (ventromedial)
D. Periaqueductal gray
Correct Answer: B
Rationale: The amygdala is central to fear acquisition and the formation of fear memories.
Successful exposure therapy is associated with decreased amygdala activation and increased
prefrontal cortex (vmPFC) inhibition of the amygdala. The hippocampus is involved in contextual
learning, the vmPFC in fear extinction, and the periaqueductal gray in fear responses, but the
amygdala is central to fear acquisition.
